Research on the Design and Development of Anti-Tumor Drug Delivery Vehicles
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".
Deadline for manuscript submissions: 20 February 2025 | Viewed by 75
Special Issue Editor
Interests: stimuli-responsive targeted drug delivery systems; NIR-II imaging and phototherapy; neuroimaging and brain regulation; biomaterials; theranostics
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
I am pleased to invite you to contribute to this Special Issue on the design and development of anti-tumor drug delivery vehicles. Cancer remains a major global health challenge, and the development of effective drug delivery systems is crucial for improving patient outcomes. This Pharmaceutics Special Issue aims to showcase the latest research on anti-tumor drug delivery vehicle development, gathering a collection of high-quality original research and review articles which will advance the field and provide valuable insights for researchers and clinicians. The research areas may include (but are not limited to) the following: nanoparticle-based drug delivery, targeted therapy, drug efficacy evaluation, and drug delivery system optimization.
I look forward to receiving your contributions.
Dr. Mengze Xu
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- anti-tumor drugs
- drug delivery vehicles
- nanoparticles
- cancer treatment
- targeted therapy
- drug efficacy
- delivery system optimization
- tumor microenvironment
- neurocognitive aspects
- drug design
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
